# Vincerx Pharma, Inc. (VINC)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/VINC/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2025 | $ 0 | $ -5.12M | $ -4.56M | $ 0 | $ 2.07M |
| 2024 | $ 1.12M | $ -31.61M | $ -27.46M | $ 0 | $ 2.72M |
| 2023 | $ 1.42M | $ -42.60M | $ -43.74M | $ 2.50M | $ 11.22M |
| 2022 | $ 0 | $ -56.70M | $ -66.58M | $ 3.44M | $ 47.67M |
| 2021 | $ 151.0K | $ -46.72M | $ -45.95M | $ 4.17M | $ 100.32M |
| 2020 | $ -1.78M | $ -13.66M | $ -2.90M | $ 0 | $ 57.69M |
| 2019 | $ 0 | $ -52.9K | $ 0 | $ 0 | $ -44.0K |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.00 |
| Liabilities / Eq | 1.27 |
| Current Ratio | 1.79 |

## Other views

- [Metrics](https://sponda.capital/en/VINC.md)
- [Charts](https://sponda.capital/en/VINC/charts.md)
- [Compare](https://sponda.capital/en/VINC/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-13.